Neuropace Inc (NPCE) is around the middle of the Medical Devices industry according to InvestorsObserver. NPCE received an overall rating of 45, which means that it scores higher than 45 percent of all stocks. Neuropace Inc also achieved a score of 55 in the Medical Devices industry, putting it above 55 percent of Medical Devices stocks. Medical Devices is ranked 84 out of the 148 industries.
NPCE has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on NPCE!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Neuropace Inc Stock Today?
Neuropace Inc (NPCE) stock is trading at $6.56 as of 10:33 AM on Monday, Aug 28, a rise of $0.56, or 9.34% from the previous closing price of $6.00. The stock has traded between $6.30 and $7.16 so far today. Volume today is less active than usual. So far 58,336 shares have traded compared to average volume of 78,991 shares.
Click Here to get the full Stock Report for Neuropace Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
